Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    EXPEDITION-EXT
Show Display Options
Rank Status Study
1 Active, not recruiting Continued Safety Monitoring of Solanezumab in Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Solanezumab

Study has passed its completion date and status has not been verified in more than two years.